Quintiles, Inc. Says It Will Not Bid for ClinPhone

LONDON, June 30 (Reuters) - Drug research firm Quintiles Transnational said on Monday it had decided not to proceed with an offer for Britain's Clinphone (CNP1.L: Quote, Profile, Research, Stock Buzz), leaving the way clear for Parexel International (PRXL.O: Quote, Profile, Research, Stock Buzz) to buy the business.

Back to news